Showing results (451-460 of 833) with videos related to
Sort By:
Pageof 84
Drug Design, Development and Therapy|July 1, 2015
Characterization of renal biomarkers for use in clinical trials: effect of preanalytical processing and qualification using samples from subjects with diabetesDavid A Brott, Stephen T Furlong, Scott H Adler, et al.Diabetes|September 24, 2015
Angiogenic microRNAs Linked to Incidence and Progression of Diabetic Retinopathy in Type 1 DiabetesAnna Zampetaki, Peter Willeit, Simon Burr, et al.Diabetes|August 2, 2020
Circulating Metabolites and Lipids Are Associated to Diabetic Retinopathy in Individuals With Type 1 DiabetesViktor Rotbain Curovic, Tommi Suvitaival, Ismo Mattila, et al.Journal of Diabetes and Its Complications|May 1, 2024
Contemporary prevalence of diabetic neuropathies in individuals with type 1 and type 2 diabetes in a Danish tertiary outpatient clinicHatice Isik Mizrak, Huda Kufaishi, Sofie Korsgaard Hecquet, et al.BMC Endocrine Disorders|June 17, 2020
Study rationale and design of the EANITIATE study (EmpAgliflozin compared to NPH Insulin for sTeroId diAbeTEs) - a randomized, controlled, multicenter trial of safety and efficacy of treatment with empagliflozin compared with NPH-insulin in patients with newly onset diabetes following initiation of glucocorticoid treatmentCarina Kirstine Klarskov, Helga Holm Schultz, Frederik Persson, et al.Acta Psychiatrica Scandinavica|January 6, 2024
The development of type 2 diabetes management in people with severe mental illness in the Capital Region of Denmark from 2001 to 2015Catrine Bakkedal, Frederik Persson, Mikkel Bring Christensen, et al.Journal of Diabetes Science and Technology|September 6, 2023
The Effect of Insulin Degludec Versus Insulin Glargine U100 on Glucose Metrics Recorded During Continuous Glucose Monitoring in People With Type 1 Diabetes and Recurrent Nocturnal Severe HypoglycemiaJulie Maria Bøggild Brøsen, Rikke Mette Agesen, Amra Ciric Alibegovic, et al.JACC. Heart Failure|June 30, 2022
Increase in BNP in Response to Endothelin-Receptor Antagonist Atrasentan Is Associated With Incident Heart FailureJ David Smeijer, Jeroen Koomen, Donald E Kohan, et al.Primary Care Diabetes|October 9, 2020
Risk factor management of type 2 diabetic patients in primary care in the Scandinavian countries between 2003 and 2015Søren Tang Knudsen, Johan Bodegård, Kåre I Birkeland, et al.Diabetes Care|August 3, 2019
The Impact of Sotagliflozin on Renal Function, Albuminuria, Blood Pressure, and Hematocrit in Adults With Type 1 DiabetesDaniël H van Raalte, Petter Bjornstad, Frederik Persson, et al.Pageof 84